Emerging in the field of excess body fat therapy, retatrutide represents a different method. Unlike many current medications, retatrutide functions as a twin agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) receptors. This concurrent stimulation encourages multiple beneficial effects… Read More